165 related articles for article (PubMed ID: 18343721)
1. Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction.
Jacobshagen C; Grüber M; Teucher N; Schmidt AG; Unsöld BW; Toischer K; Nguyen VP; Maier LS; Kögler H; Hasenfuss G
Eur J Heart Fail; 2008 Apr; 10(4):334-42. PubMed ID: 18343721
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib and 2,5-dimethyl-celecoxib prevent cardiac remodeling inhibiting Akt-mediated signal transduction in an inherited dilated cardiomyopathy mouse model.
Fan X; Takahashi-Yanaga F; Morimoto S; Zhan DY; Igawa K; Tomooka K; Sasaguri T
J Pharmacol Exp Ther; 2011 Jul; 338(1):2-11. PubMed ID: 21430081
[TBL] [Abstract][Full Text] [Related]
3. 2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation.
Morishige S; Takahashi-Yanaga F; Ishikane S; Arioka M; Igawa K; Kuroo A; Tomooka K; Shiose A; Sasaguri T
Biochem Pharmacol; 2019 Oct; 168():82-90. PubMed ID: 31229551
[TBL] [Abstract][Full Text] [Related]
4. 2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation.
Fujita A; Takahashi-Yanaga F; Morimoto S; Yoshihara T; Arioka M; Igawa K; Tomooka K; Hoka S; Sasaguri T
Hypertens Res; 2017 Feb; 40(2):130-139. PubMed ID: 27628899
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours.
Kucab JE; Lee C; Chen CS; Zhu J; Gilks CB; Cheang M; Huntsman D; Yorida E; Emerman J; Pollak M; Dunn SE
Breast Cancer Res; 2005; 7(5):R796-807. PubMed ID: 16168126
[TBL] [Abstract][Full Text] [Related]
6. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling.
Kim N; Kim CH; Ahn DW; Lee KS; Cho SJ; Park JH; Lee MK; Kim JS; Jung HC; Song IS
J Gastroenterol Hepatol; 2009 Mar; 24(3):480-7. PubMed ID: 18823436
[TBL] [Abstract][Full Text] [Related]
7. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
8. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
[TBL] [Abstract][Full Text] [Related]
9. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload.
Miyamoto T; Takeishi Y; Takahashi H; Shishido T; Arimoto T; Tomoike H; Kubota I
Basic Res Cardiol; 2004 Sep; 99(5):328-37. PubMed ID: 15309410
[TBL] [Abstract][Full Text] [Related]
10. Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress.
Oudit GY; Kassiri Z; Zhou J; Liu QC; Liu PP; Backx PH; Dawood F; Crackower MA; Scholey JW; Penninger JM
Cardiovasc Res; 2008 Jun; 78(3):505-14. PubMed ID: 18281373
[TBL] [Abstract][Full Text] [Related]
11. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling.
Yang HM; Kim HS; Park KW; You HJ; Jeon SI; Youn SW; Kim SH; Oh BH; Lee MM; Park YB; Walsh K
Circulation; 2004 Jul; 110(3):301-8. PubMed ID: 15238462
[TBL] [Abstract][Full Text] [Related]
15. Activating PTEN by COX-2 inhibitors antagonizes radiation-induced AKT activation contributing to radiosensitization.
Meng Z; Gan YH
Biochem Biophys Res Commun; 2015 May; 460(2):198-204. PubMed ID: 25770423
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.
Kato MF; Shibata R; Obata K; Miyachi M; Yazawa H; Tsuboi K; Yamada T; Nishizawa T; Noda A; Cheng XW; Murate T; Koike Y; Murohara T; Yokota M; Nagata K
J Hypertens; 2008 Aug; 26(8):1669-76. PubMed ID: 18622247
[TBL] [Abstract][Full Text] [Related]
17. KS370G, a synthetic caffeamide derivative, improves left ventricular hypertrophy and function in pressure-overload mice heart.
Weng YC; Chuang CF; Chuang ST; Chiu HL; Kuo YH; Su MJ
Eur J Pharmacol; 2012 Jun; 684(1-3):108-15. PubMed ID: 22484506
[TBL] [Abstract][Full Text] [Related]
18. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.
Deres L; Bartha E; Palfi A; Eros K; Riba A; Lantos J; Kalai T; Hideg K; Sumegi B; Gallyas F; Toth K; Halmosi R
PLoS One; 2014; 9(7):e102148. PubMed ID: 25014216
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9.
Ding H; Han C; Zhu J; Chen CS; D'Ambrosio SM
Int J Cancer; 2005 Feb; 113(5):803-10. PubMed ID: 15499625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
